Our study is strengthened by the classification of endometrial cancers into four molecular subgroups based on TCGA4 which allowed analyses of NSMP, that is, MMR proficient subgroup from which p53 abn and POLE EDM cases are excluded. This evidence concerns the gene POLE and endometrial cancer.